Streptococcus pyogenes Rosenbach (ATCC® BAA-1633)

Strain Designations: NZ131  /  Type Strain: no  /  Biosafety Level: 2

Permits and Restrictions

View Permits

Strain Designations NZ131
Emerging infectious disease research
Isolation Post-streptococcal glomerulonephritis, 1991
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format frozen
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Preceptrol® no
Genome Sequenced Strain


Type Strain no
Depositor states that this strain is Lancefield serotype M49
Genome sequenced strain
Group A
Name of Depositor M. McShan; Oklahoma University Health Sciences Center
Isolation Post-streptococcal glomerulonephritis, 1991

Simon D, Ferretti JJ. Electrotransformation of Streptococcus pyogenes with plasmid and linear DNA. FEMS Microbiol Lett. 1991 Aug 1;66(2):219-24. PMID: 1936949

Cross References

Nucleotide (Genbank) : U21934 Streptococcus pyogenes RecA (recA) gene, complete cds

Nucleotide (GenBank) : AF091252 Streptococcus pyogenes Rgg (rgg) and cysteine proteinase SPE B (speB) genes, partial cds.

Nucleotide (GenBank) : AF277384 Streptococcus pyogenes strain NZ131 NAD-glycohydrolase (nga) gene, complete cds.

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation